Development and Validation of the Steatotic Liver Disease Lab Data Index: A Refined Diagnostic Tool.
A simple blood test predicts liver disease without biopsy, enabling easier screening in primary care and busy clinics.
This Taiwanese study develops and validates a refined laboratory data index for non-invasive diagnosis of steatotic liver disease, using routinely available metabolic and hepatic biomarkers in a large clinical cohort. The tool addresses an important need for simple, accessible liver disease staging in primary care and gastroenterology settings where liver biopsy is impractical for population-level screening.
What the study was
- Study design
- Validation study (diagnostic index development)
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- Can J Gastroenterol Hepatol
Why it surfaced
MASLD/NAFLD is a global epidemic with major diagnostic unmet need; non-invasive fibrosis/steatosis staging is an active clinical research area; validation study design.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.